Meningococcemia classification

Meningococcemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Meningococcemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Treatment
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Meningococcemia classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Meningococcemia classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Meningococcemia classification
CDC on Meningococcemia classification
Meningococcemia classification in the news
Blogs on Meningococcemia classification
Directions to Hospitals Treating Meningococcemia
Risk calculators and risk factors for Meningococcemia classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Classification

• The polysaccharide capsule is the basis of the serogroup typing system.
• 13 Serotypes are described based on capsular polysaccharide: A, B, C, D, X, Y, Z, E, W-135, H, I, K, and L.
• Serogroup A usually with epidemics in less developed nations and an attack rate of as high as 500 cases per 100,000 population.
• Serogroup B usually in developed nations with attack rate of 50-100 cases per 100,000 population.
• Serogroup C usually in both developed and less developed populations and an attack rate of up to 500 per 100,000 population.